Literature DB >> 17394948

Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests.

Kwang Woon Kim1, Robert W Mutter, Christopher D Willey, Ty K Subhawong, Eric T Shinohara, Jeffrey M Albert, Geng Ling, Carolyn Cao, Young Jin Gi, Bo Lu.   

Abstract

PURPOSE: Survivin, a member of the inhibitor of apoptosis gene family, has also been shown to regulate mitosis. It binds Aurora B kinase and the inner centromere protein to form the chromosome passenger complex. Both Aurora B and survivin are overexpressed in many tumors. In this study, we examined whether irradiation affected survivin and Aurora B expression in mesothelioma cells, and how inhibition of these molecules affected radiosensitivity. METHODS AND MATERIALS: ZM447439 and survivin antisense oligonucleotides were used to inhibit survivin and Aurora B kinase respectively. Western blot was performed to determine the expression of survivin, Aurora B, phosphorylated-histone H3 (Ser 10), and caspase cleavage. Multinucleated cells were counted using flow cytometry, and cell survival after treatment was determined using clonogenic assay.
RESULTS: At 3-Gy irradiation an increase was observed in levels of survivin and Aurora B as well as the kinase activity of Aurora B, with an increase in G2/M phase. The radiation-induced upregulation of these molecules was effectively attenuated by antisense oligonucleotides against survivin and a small-molecule inhibitor of Aurora B, ZM447439. Dual inhibition of survivin and Aurora B synergistically radiosensitized mesothelioma cells with a dose enhancement ratio of 2.55. This treatment resulted in increased formation of multinucleated cells after irradiation but did not increase levels of cleaved caspase 3.
CONCLUSION: Inhibition of survivin and Aurora B induces mitotic cell arrest in mesothelioma cells after irradiation. These two proteins may be potential therapeutic targets for the enhancement of radiotherapy in malignant pleural mesothelioma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17394948     DOI: 10.1016/j.ijrobp.2006.12.018

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis.

Authors:  Anand Singh; Nisan Bhattacharyya; Abhishek Srivastava; Nathanael Pruett; R Taylor Ripley; David S Schrump; Chuong D Hoang
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

2.  Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.

Authors:  Kenneth J Niermann; Luigi Moretti; Nicholas J Giacalone; Yunguang Sun; Stephen M Schleicher; Prapaporn Kopsombut; Lauren R Mitchell; Kwang Woon Kim; Bo Lu
Journal:  Radiat Res       Date:  2011-01-11       Impact factor: 2.841

3.  BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.

Authors:  Julija Hmeljak; Nina Erčulj; Vita Dolžan; Izidor Kern; Andrej Cör
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-23       Impact factor: 4.553

4.  Cytoskeletal Associated Filamin A and RhoA Affect Neural Progenitor Specification During Mitosis.

Authors:  Gewei Lian; Timothy Wong; Jie Lu; Jianjun Hu; Jingping Zhang; Volney Sheen
Journal:  Cereb Cortex       Date:  2019-03-01       Impact factor: 5.357

5.  Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.

Authors:  Yunguang Sun; Nicholas J Giacalone; Bo Lu
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

6.  Is survivin expression prognostic or predictive in malignant pleural mesothelioma?

Authors:  Julija Hmeljak; Nina Erčulj; Vita Dolžan; Jože Pižem; Izidor Kern; Viljem Kovač; Maja Cemažar; Andrej Cör
Journal:  Virchows Arch       Date:  2013-01-29       Impact factor: 4.064

7.  Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.

Authors:  Nicholas R Galloway; Jonathan R Aspe; Chelsey Sellers; Nathan R Wall
Journal:  Pancreas       Date:  2009-10       Impact factor: 3.327

8.  Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma.

Authors:  Alfonso Baldi; Maria Teresa Piccolo; Maria Rosaria Boccellino; Aldo Donizetti; Irene Cardillo; Raffaele La Porta; Lucio Quagliuolo; Enrico P Spugnini; Francesca Cordero; Gennaro Citro; Massimo Menegozzo; Raffaele A Calogero; Stefania Crispi
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  Forced Expression of ZNF143 Restrains Cancer Cell Growth.

Authors:  Hiroto Izumi; Yoshihiro Yasuniwa; Masaki Akiyama; Takahiro Yamaguchi; Akihiro Kuma; Noriaki Kitamura; Kimitoshi Kohno
Journal:  Cancers (Basel)       Date:  2011-10-19       Impact factor: 6.639

10.  Inhibition of Aurora B by CCT137690 sensitizes colorectal cells to radiotherapy.

Authors:  Xiaoyu Wu; Wentao Liu; Qinhong Cao; Che Chen; Zhiwei Chen; Zhe Xu; Weisu Li; Fukun Liu; Xuequan Yao
Journal:  J Exp Clin Cancer Res       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.